ClinicalTrials.gg
Not yet recruitingNCT07401056READY-LUNGUpdated Feb 12, 2026

Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung Cancer

An interventional study of Prehabilitation (Structured Preoperative Exercise Programme) in Non-Small Cell Lung Cancer, sponsored by Hacettepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Hacettepe University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 255 studies in Carcinoma, Non-Small-Cell Lung with a site in Turkey — 62 open to participants now, 145 under way, 94 of them phase 3. Carcinoma, Non-Small-Cell Lung · Turkey.

Planned enrollment
217th of 242
62 · median 413
Started
2026
with 13 others
No phase
10 of 255
6 open now
Primary completion
2027-02
later than 60 of 144 live
Registered
247th of 255
by date

Among the 255 studies in Carcinoma, Non-Small-Cell Lung with a site in Turkey, this one is the 217th largest by planned enrollment of the 242 interventional ones that give a count, is one of 14 that started in 2026, is one of 10 with no phase, reaches primary completion later than 60 of the 144 other live ones, and was the 247th registered.

Carcinoma, Non-Small-Cell Lung

7,638 studies on the registry are indexed under Carcinoma, Non-Small-Cell Lung; 1,838 are open to participants now.

Browse Carcinoma, Non-Small-Cell Lung studies →

Open to participants now

62 of the 255 studies in Carcinoma, Non-Small-Cell Lung with a site in Turkey are open now. Recruiting first, the newest first:

57 more — sign in →

All 62 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,324 Carcinoma, Non-Small-Cell Lung studies recruiting now, 987 (75%) set no upper age limit and 225 (17%) stop at 75 or younger; 34 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 255 studies in Carcinoma, Non-Small-Cell Lung with a site in Turkey, or all of them as a file.
02

Study summary

INTRODUCTION: Lung cancer is among the leading cancers, and surgery has a major role in treatment. Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC) who are eligible for surgical treatment have a high risk of experiencing postoperative complications. Therefore, in recent years, the concept of prehabilitation has begun to gain importance. Within the scope of prehabilitation practices, patients are provided with programmes that include aerobic exercises and breathing exercises in the preoperative period.

AIM: This study aims to evaluate the effects of a structured exercise programme, including aerobic exercises and breathing exercises in the preoperative period, on postoperative pain severity, surgical recovery level, length of hospital stays (LOS), and quality of life (QoL) in patients diagnosed with NSCLC and planned for surgical treatment.

METHODS: The research is an experimental, parallel group-randomised controlled trial to be conducted with 62 participants followed in the Thoracic Surgery Outpatient Clinic of Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital and scheduled for surgery due to NSCLC. Patients will be equally assigned to the intervention and control groups using the block randomization method. In the intervention group, in the preoperative period, for two weeks and five days per week, at least 30 minutes of walking per day will be performed; in addition, for two weeks before surgery, throughout the entire week, during waking hours, 10 repetitions with incentive spirometer every hour, and daily four sessions of deep breathing \& coughing exercises will be performed as breathing exercises. In the control group, routine preoperative clinical procedures will be applied. In the postoperative period, pain severity, surgical recovery level, LOS, and QoL will be compared between the two groups. Data will be collected face-to-face by the researcher using the "Descriptive Characteristics Form", "EQ-5D-5L Quality of Life Scale", "Numeric Rating Scale (NRS)", and "Surgical Recovery Scale". Data on the length of hospital stay will be obtained from patient files. The data will be analysed using parametric and/or nonparametric tests through the SPSS.

CONCLUSION: The findings of the study are expected to contribute to strengthening holistic care approaches for the preoperative period in surgical nursing practices and to improving patient outcomes.

03

Conditions studied

  • Non-Small Cell Lung Cancer

Keywords

  • exercise
  • discharge
  • lung cancer
  • pain
  • prehabilitation
  • quality of life
  • recovery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 18 years.
  2. Ownership of a smartphone capable of tracking daily walking time.
  3. Diagnosis of primary non-small cell lung cancer.
  4. ASA () classification I, II, or III.
  5. Follow-up and treatment provided by the same surgical team.
  6. No physical or cognitive impairment that would hinder participation in the study.

Exclusion criteria

Exclusion Criteria

  1. Diagnosis of recurrent lung cancer.
  2. Previous radiotherapy treatment prior to surgery.
  3. Any condition preventing walking or exercise (orthopedic, neurological, cardiovascular, , etc.).
  4. Diagnosis of additional respiratory system disease such as , asthma, or emphysema preventing breathing exercises.
  5. Inability to complete the two-week structured exercise programme due to surgery being scheduled earlier or later than planned.
  6. Complications resulting in prolonged (>24 hours) intensive care unit stay after surgery.
  7. Inability to discontinue or continue the structured exercise programme at any stage.
  8. Refusal to participate in the study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Prehabilitation (Structured Preoperative Exercise Programme)

    Other: Prehabilitation (Structured Preoperative Exercise Programme)

  • No intervention
    Control Group

    Control: Partients in this arm will receive standard preoperative care without a structured exercise programme. Study-related data will be collected from patients admitted to the hospital at the end of the two-week preoperative period in accordance with the study protocol. In this regard, the measurements to be taken in the study will include: (1) Pain severity: At 6, 12, 24 and 48 hours after surgery; (2) Surgical recovery level: On the third and seventh days after surgery; (3) Quality of life: On the first day before surgery and on the seventh day after surgery. (4) In addition, patients' LOSs will be recorded.

Interventions

  • OtherPrehabilitation (Structured Preoperative Exercise Programme)

    Participants in this arm will receive a structured preoperative exercise programme starting two weeks before surgery. The programme includes moderate-intensity walking for at least 30 minutes 5 days per week, deep breathing and coughing exercises four times daily, and hourly incentive spirometry exercises while awake. Participants will record daily adherence to the exercise programme, and compliance will be monitored through daily telephone follow-up by the researcher. Study-related data will be collected from patients admitted to the hospital at the end of the two-week preoperative period in accordance with the study protocol. In this regard, the measurements to be taken in the study will include: (1) Pain severity: At 6, 12, 24 and 48 hours after surgery; (2) Surgical recovery level: On the third and seventh days after surgery; (3) Quality of life: On the first day before surgery and on the seventh day after surgery. (4) In addition, patients' LOSs will be recorded.

06

What researchers measure

Primary outcomes

  1. Health-Related Quality of Life (EQ-5D-5L)

    The EQ-5D-5L is a self-reported questionnaire assessing five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels: no problems, mild problems, moderate problems, severe problems, and extreme problems. The questionnaire also includes a Visual Analog Scale (VAS) ranging from 0 (worst health) to 100 (best health) for participants to rate their current health status. Higher scores indicate better health.

    Time frame: Change from baseline scores on the 7th postoperative day.

  2. Postoperative Pain Intensity (Numeric Rating Scale, NRS)

    The NRS is an 11-point scale (0-10) used to assess pain intensity, where 0 indicates no pain and 10 indicates the worst possible pain. Patients rate their pain at each time point, and the average of the measurements will be used to assess postoperative pain. The NRS is validated for adults, including elderly patients and those with mild-to-moderate cognitive impairment.

    Time frame: Change from baseline scores on the 48 hours postoperatively.

  3. Postoperative Surgical Recovery (Surgical Recovery Scale)

    The Surgical Recovery Scale is a 13-item questionnaire assessing two sub-dimensions: "Impact on energy" and "Impact on daily activities." Items are scored using 6-point Likert scales, with higher scores indicating better recovery. The total score ranges from 8 to 73. This scale is validated with a Cronbach's α of 0.93.

    Time frame: Change from baseline scores on the 7th postoperative day.

Secondary outcomes

  1. Length of Hospital Stay

    Patients' discharge time will be recorded and compared in both groups.

    Time frame: Approximately the seventh day.

07

Study locations

1 site
  • Hacettepe University, Ankara, Altındağ 06230
    Ankara, Turkey (Türkiye)
08

References and documents

Publications

  • Yilmaz B, Yayla A. Validity and Reliability Study of the Turkish Version of the Surgical Recovery Scale. J Perianesth Nurs. 2025 Oct;40(5):1281-1289. doi: 10.1016/j.jopan.2025.01.023. Epub 2025 Jun 20. PubMed 40542811 ↗
  • Machado P, Pimenta S, Garcia AL, Nogueira T, Silva S, Dos Santos CL, Martins MV, Canha A, Oliveiros B, Martins RA, Cruz J. Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial. Ann Surg Oncol. 2024 Feb;31(2):847-859. doi: 10.1245/s10434-023-14503-2. Epub 2023 Nov 7. PubMed 37934383 ↗
  • Jiao M, Liang H, Zhang M. Effect of exercise on postoperative recovery of patients with non-small cell lung cancer: a systematic review and meta-analysis. Discov Oncol. 2024 Jun 17;15(1):230. doi: 10.1007/s12672-024-01079-w. PubMed 38884823 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Feb 2027, 12 months later.

Of 345 non-industry interventional studies with no phase under Carcinoma, Non-Small-Cell Lung, half reached primary completion within 52 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 97. This study's planned 12 months is below that.

Counting every sponsor, half of 361 studies reached it within 51 months; a quarter within 26 and three quarters within 97.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2026
First posted
Feb 10, 2026
StartEst.
Feb 2026
Primary completionEst.
Feb 2027
CompletionEst.
Mar 2027
Last update
Feb 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07401056
Responsible party
Burcu Duluklu (Asst. Prof., Hacettepe University) — Principal investigator
First posted
Feb 10, 2026
Start date
Feb 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Feb 12, 2026

Study contacts

Burcu Duluklu, Asst. Prof.
Contact
duluklu@gmail.com
+905334732070
Melisa T Öncü, Graduate Student
Contact
tur.melisa.oncu@gmail.com
+905068207312
Burcu Duluklu, Asst. Prof.
principal investigator · Hacettepe University, Faculty of Nursing, Surgical Nursing Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion